These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38654237)

  • 1. Phenotypic and molecular characterization of β-lactamase-producing Klebsiella species among children discharged from hospital in Western Kenya.
    Rwigi D; Nyerere AK; Diakhate MM; Kariuki K; Tickell KD; Mutuma T; Tornberg SN; Soge OO; Walson JL; Singa B; Kariuki S; Pavlinac PB; Mogeni P
    BMC Microbiol; 2024 Apr; 24(1):135. PubMed ID: 38654237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmid-mediated quinolone resistance genes detected in Ciprofloxacin non-susceptible Escherichia coli and Klebsiella isolated from children under five years at hospital discharge, Kenya.
    Kariuki K; Diakhate MM; Musembi S; Tornberg-Belanger SN; Rwigi D; Mutuma T; Mutuku E; Tickell KD; Soge OO; Singa BO; Walson JL; Pavlinac PB; Kariuki S
    BMC Microbiol; 2023 May; 23(1):129. PubMed ID: 37173674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Travel to Asia is a strong predictor for carriage of cephalosporin resistant
    Espenhain L; Jørgensen SB; Leegaard TM; Lelek MM; Hänsgen SH; Nakstad B; Sunde M; Steinbakk M
    Antimicrob Resist Infect Control; 2018; 7():146. PubMed ID: 30534366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faecal colonization of E. coli and Klebsiella spp. producing extended-spectrum beta-lactamases and plasmid-mediated AmpC in Mozambican university students.
    Chirindze LM; Zimba TF; Sekyere JO; Govinden U; Chenia HY; Sundsfjord A; Essack SY; Simonsen GS
    BMC Infect Dis; 2018 May; 18(1):244. PubMed ID: 29843632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phenotypic and molecular identification of extended-spectrum beta-lactamase (ESBL) TEM and SHV produced by clinical isolates Escherichia coli and Klebsiella spp. in hospitals].
    González Mesa L; Ramos Morí A; Nadal Becerra L; Morffi Figueroa J; Hernández Robledo E; Alvarez AB; Marchena Bequer JJ; González Alemán M; Villain Plous C
    Rev Cubana Med Trop; 2007; 59(1):52-8. PubMed ID: 23427419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistance and extended-spectrum beta-lactamase producing Gram-negative bacteria from three Referral Hospitals of Amhara region, Ethiopia.
    Moges F; Gizachew M; Dagnew M; Amare A; Sharew B; Eshetie S; Abebe W; Million Y; Feleke T; Tiruneh M
    Ann Clin Microbiol Antimicrob; 2021 Mar; 20(1):16. PubMed ID: 33706775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of extended-spectrum β-lactamase (ESBL) and molecular detection of
    Dirar MH; Bilal NE; Ibrahim ME; Hamid ME
    Pan Afr Med J; 2020; 37():213. PubMed ID: 33520052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the phenotype and genotype of multi-drug resistant Klebsiella pneumoniae harbouring bla
    Patil S; Chen X; Wen F
    Ann Clin Microbiol Antimicrob; 2019 Nov; 18(1):32. PubMed ID: 31690324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of extended-spectrum beta-lactamase and molecular detection of blaTEM, blaSHV, and blaCTX-M genotypes among gram-negative Bacilli isolates from hospital acquired infections in pediatrics, one institutional study.
    Elsayed AGA; Badr DF; El Kheir NYA; Zaki MES; Mossad AEM; Mahmoud EMF
    Ital J Pediatr; 2024 Feb; 50(1):31. PubMed ID: 38402215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High burden of ESBL and carbapenemase-producing gram-negative bacteria in bloodstream infection patients at a tertiary care hospital in Addis Ababa, Ethiopia.
    Beshah D; Desta AF; Woldemichael GB; Belachew EB; Derese SG; Zelelie TZ; Desalegn Z; Tessema TS; Gebreselasie S; Abebe T
    PLoS One; 2023; 18(6):e0287453. PubMed ID: 37368908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decline in AmpC β-lactamase-producing Escherichia coli in a Dutch teaching hospital (2013-2016).
    den Drijver E; Verweij JJ; Verhulst C; Oome S; Soer J; Willemsen I; Schrauwen EJA; Kluytmans-van den Bergh MFQ; Kluytmans JAJW
    PLoS One; 2018; 13(10):e0204864. PubMed ID: 30273375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nosocomial and community infections due to class A extended-spectrum β-lactamase (ESBLA)-producing Escherichia coli and Klebsiella spp. in southern Brazil.
    Wollheim C; Guerra IM; Conte VD; Hoffman SP; Schreiner FJ; Delamare AP; Barth AL; Echeverrigaray S; Costa SO
    Braz J Infect Dis; 2011; 15(2):138-43. PubMed ID: 21503400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole Genome Sequencing of Extended Spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae Isolated from Hospitalized Patients in KwaZulu-Natal, South Africa.
    Founou RC; Founou LL; Allam M; Ismail A; Essack SY
    Sci Rep; 2019 Apr; 9(1):6266. PubMed ID: 31000772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial resistance of Klebsiella pneumoniae stool isolates circulating in Kenya.
    Taitt CR; Leski TA; Erwin DP; Odundo EA; Kipkemoi NC; Ndonye JN; Kirera RK; Ombogo AN; Walson JL; Pavlinac PB; Hulseberg C; Vora GJ
    PLoS One; 2017; 12(6):e0178880. PubMed ID: 28575064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients.
    Wener KM; Schechner V; Gold HS; Wright SB; Carmeli Y
    Antimicrob Agents Chemother; 2010 May; 54(5):2010-6. PubMed ID: 20211888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and patient related factors associated with Extended-Spectrum Beta-Lactamase producing Escherichia coli and Klebsiella pneumoniae carriage and infection among pediatric patients in Tanzania.
    Letara N; Ngocho JS; Karami N; Msuya SE; Nyombi B; Kassam NA; Skovbjerg S; Åhren C; Philemon R; Mmbaga BT
    Sci Rep; 2021 Nov; 11(1):22759. PubMed ID: 34815472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and Genotypic Characterization of Extended Spectrum Beta-Lactamase-Producing Clinical Isolates of
    Maveke SM; Aboge GO; Kanja LW; Mainga AO; Gachau N; Muchira BW; Moriasi GA
    Int J Microbiol; 2024; 2024():7463899. PubMed ID: 38384586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance and clonality in Escherichia coli and Klebsiella spp. and relationship with antibiotic consumption in major Lebanese hospitals.
    Daoud Z; Salem-Sokhn E; Dahdouh E; Irani J; Matar GM; Doron S
    J Glob Antimicrob Resist; 2017 Dec; 11():45-51. PubMed ID: 28756026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae fecal carriage among children under five years in Addis Ababa, Ethiopia.
    Tola MA; Abera NA; Gebeyehu YM; Dinku SF; Tullu KD
    PLoS One; 2021; 16(10):e0258117. PubMed ID: 34597328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Outbreak of ESBL-producing Klebsiella pneumoniae in an Iranian Referral Hospital: Epidemiology and Molecular Typing.
    Mahmoudi S; Pourakbari B; Rahbarimanesh A; Abdosalehi MR; Ghadiri K; Mamishi S
    Infect Disord Drug Targets; 2019; 19(1):46-54. PubMed ID: 29732983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.